Clinical Trial

The MAI-FOIE Cohort

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The MAI-FOIE cohort will be a French multicenter cohort with the development of a biobank including patients with autoimmune, metabolic and medicated liver diseases
Protocol Amendment History 1 change
notable Trial sites expanded: 1 -> 13 locations 2026-06-26
Trial Details
NCT Number NCT07594990
Lead Sponsor Nantes University Hospital
Collaborators: Direction Générale de l'Offre de Soins, Institut National de la Santé Et de la Recherche Médicale, France, National Cancer Institute, France, French Association for the Study of the Liver, ALBI, FILFOIE, GIRCIGO, CR2TI-U1064, HEPATIM-GO network, CIC IMAD
Conditions Autoimmune Liver Diseases, Immunological Mechanisms
Enrollment 800 participants
Start Date 2026-06-01
Primary Completion 2028-05-30 (estimated)
Study Completion 2038-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-25